|
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Ebiquity PLC - London-based firm provides clients with advice on how to maximise advertising spending - Says global operations, excluding North America, which represent around 85% of revenue, have continued to deliver growth in the second half of the financial year and are expected to deliver strong full-year revenue and operating profit growth, particularly in Marketing Effectiveness and Contract Compliance services. But cautions that the uncertain macroeconomic environment in North America has proved more persistent than previously anticipated, having negative impacts on client spending. As a result, Ebiquity has restructured the North American leadership team and is implementing targeted cost savings to improve profitability. It now expects full-year revenue ‘in the region of’ £75 million, ‘in line’ with £76.8 million in 2024, and an adjusted operating profit ‘in the region’ of £5.5 million, down from £7.9 million in 2024. ---------- BP Marsh & Partners PLC - London-based private equity firm, investing in early-stage financial services businesses - Reports a continued strong performance from the portfolio in the six months to July 31. In a trading update, BP Marsh highlights a ‘robust pipeline of potential new and follow-on investments.’ At July 31, group funds stood at £52.6 million. ‘With a robust liquidity position and a proven investment track record, the group is well placed to capitalise on this healthy pipeline and to continue delivering attractive opportunities that will support long-term shareholder returns,’ it adds. BP Marsh says it continues to closely monitor developments across the insurance sector, and notes that parts of the market are softening. ---------- Kooth PLC - London-based firm offers digital mental health services and has contracts with the Californian state government as well as the NHS - Swings to a pretax loss of £1.7 million in the six months to June 30 from a £5.0 million profit a year ago. Revenue nudges down to £32.1 million from £32.5 million while cost of sales more than doubles to £11.9 million from £5.7 million. Sales drop reflects the impact of a £0.8 million negative foreign exchange movement together with contract changes, largely in the UK, that reduce revenue by £0.6 million, offset by a £0.6 million New Jersey contract win and £0.4 million of additional revenue recognition in California. Expects to deliver revenue and adjusted earnings before interest, tax, depreciation and amortisation in line with expectations for the year before accounting for the potential impact of foreign exchange movements. At current rates the expected impact will be to reduce full year consensus median revenue of £66.8 million by 2% to 3% and consensus median adjusted Ebitda of £10.2 million by 6% to 8%. ---------- Carr’s Group PLC - Carlisle, England-based agriculture products, including livestock supplements - Expects to report revenue of £78 million in the financial year to August 31, compared to £80 million company compiled consensus, and adjusted operating profit in line with current market expectations of £3.6 million. In 2024, Carr’s reported revenue of £75 million and adjusted operating profit of £2.2 million. Says revenue grew by 3.5%, or 5.6% on a constant currency basis, with expansion of both gross and operating margins as well as continued progress in central costs reduction. The UK business continues to benefit from the streamlining of commercial and operational activities while performance in the US was primarily driven by strong volumes in northern states. ‘As we move into our peak seasonal trading period, all markets are trading in line with management expectations. We continue to actively investigate opportunities for selective entry into the expanding southern hemisphere markets and remain encouraged by the opportunities available,’ company adds. In addition, Carr’s plans a name change to Fevara PLC in October. ---------- hVIVO PLC - London-based contract research organisation testing vaccines for infectious and respiratory diseases - Swings to pretax loss of £138,000 in the six months to June 30 from a profit of £7.2 million a year prior. Revenue drops to £24.2 million from £35.6 million which hVIVO says is in line with expectations of £47 million for the full year. Basic adjusted earnings per share total 0.29 pence compared to 0.81p last year. Says trading is in line with market expectations and expects low-single digit earnings before interest, tax, depreciation and amortisation loss, pre-exceptional items, for the full year. ‘Macroeconomic and sector specific headwinds continue to impact the human challenge trials [HCT] opportunity conversion rate which the board expects to be transitory. hVIVO expects to achieve high-single digit revenue growth in 2026 on the back of anticipated growth in its newly diversified services and moving towards a normalisation of HCT activity,’ it adds. ---------- Mission Group PLC - Devon, England based owner of a group of digital marketing and communications agencies - Swings to pretax loss of £4.0 million in the six months to June from a £48,000 profit a year prior. Turnover falls to £83.4 million from £94.4 million. For continuing operations, pretax profit amounts to £1.1 million, up from £0.6 million a year prior, while revenue drops 4.5% to £33.7 million from £35.3 million. As in previous years, Mission Group expects the majority of its profit to be generated in the second half of the year. ‘While we remain very mindful of the challenging trading environment, the group currently remains on track to meet full-year headline operating profit and margin expectations,’ it adds. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
